首页> 外文期刊>Drug Design, Development and Therapy >Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
【24h】

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease

机译:阿魏酸在帕金森氏病鱼藤酮模型中的神经保护潜力

获取原文
           

摘要

Abstract: Parkinson’s disease (PD) is a chronic, progressive, and the second most common form of neurodegenerative disorders. In order to explore novel agents for the treatment of PD, in the current study, we have evaluated the neuroprotective efficacy of ferulic acid (FA) using rotenone (ROT)-induced rat model of PD. ROT was administered 2.5?mg/kg body weight to male Wistar rats for 4?weeks to induce the PD. Since PD is progressive and chronic in nature, the paradigm for evaluating FA was based on chronic administration for 4?weeks at the dose of 50?mg/kg, 30?minutes prior to ROT administration. ROT administration caused significant reduction in endogenous antioxidants such as superoxide dismutase, catalase, and glutathione. ROT challenge-induced lipid peroxidation evidenced by increased malondialdehyde following perturbation of antioxidant defense. Apart from oxidative stress, ROT also activated proinflammatory cytokines and enhanced inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase. The immunofluorescence analysis revealed a significant increase in the number of activated microglia and astrocytes accompanied by a significant loss of dopamine (DA) neurons in the substantia nigra pars compacta area upon ROT injection. However, treatment with FA rescued DA neurons in substantia nigra pars compacta area and nerve terminals in the striatum from the ROT insult. FA treatment also restored antioxidant enzymes, prevented depletion of glutathione, and inhibited lipid peroxidation. Following treatment with FA, the inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase and proinflammatory cytokines were also reduced. Further, the results were supported by a remarkable reduction of Iba-1 and GFAP hyperactivity clearly suggests attenuation of microglial and astrocytic activation. Results of our study suggest that FA has promising neuroprotective effect against degenerative changes in PD, and the protective effects are mediated through its antioxidant and anti-inflammatory properties.
机译:摘要:帕金森氏病(PD)是一种慢性,进行性疾病,是神经退行性疾病的第二大最常见形式。为了探索用于治疗PD的新型药物,在当前研究中,我们使用鱼藤酮(ROT)诱导的PD大鼠模型评估了阿魏酸(FA)的神经保护功效。对雄性Wistar大鼠给予ROT 2.5?mg / kg体重4?周以诱导PD。由于PD本质上是渐进的和慢性的,因此评估FA的范例是在ROT给药前30分钟以50?mg / kg的剂量连续4周进行慢性给药。施用ROT可以显着减少内源性抗氧化剂,例如超氧化物歧化酶,过氧化氢酶和谷胱甘肽。 ROT挑战诱导的脂质过氧化作用由抗氧化防御的微扰后丙二醛含量增加证明。除了氧化应激,ROT还激活促炎细胞因子并增强了炎症介质,例如环氧合酶2和诱导型一氧化氮合酶。免疫荧光分析显示,经ROT注射后,黑质致密部区域中激活的小胶质细胞和星形胶质细胞数量显着增加,同时多巴胺(DA)神经元明显丢失。然而,用FA的治疗可以挽救黑质中的DA神经元,从而防止ROT侵害致密组织区域和纹状体神经末梢。 FA处理还恢复了抗氧化酶,防止了谷胱甘肽的消耗,并抑制了脂质过氧化。用FA治疗后,炎症介质(如环氧合酶2和诱导型一氧化氮合酶)和促炎细胞因子也减少了。此外,结果得到Iba-1显着降低的支持,而GFAP过度活跃明显表明小胶质细胞和星形胶质细胞活化的减弱。我们的研究结果表明,FA具有抗PD退行性变化的神经保护作用,其保护作用是通过其抗氧化和抗炎特性介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号